The week in review


We take a look back at the last week in Australian pharmacy

Australia Day (or Invasion Day) week in community pharmacy didn’t start well, as the latest round of PBS price disclosure cuts were announced. Rosuvastatin alone is to experience price drops of more than 35% across a range of different tablet sizes.

We saw several health sector stakeholders release their pre-budget submissions, with the AMA calling for an end to health funding cuts, and ASMI calling for a “switch” agenda to enhance the possibility of downscheduling more medicines.

And children’s health was a focus. The February Epidemic is looming for kids who have asthma, while the often-controversial topics of ADHD and Autism Spectrum Disorder were a focus.

This week, AJP also took a look at what you see as the biggest challenges facing the profession in 2017. At the time of writing – a couple of frontrunning options were neck and neck – you saw the biggest problems as low employee wages (55% of respondents), lack of recognition of pharmacists as healthcare professionals (54%) and declining PBS dispensary income (54%).

But on the bright side, pharmacists including Gabrielle Cooper and Mary Hemming were named in the 2017 Australia Day honours. Congratulations to both and also to Dr Graeme Blackman, former chair of Medicines Australia.

Previous Arthritis isn't just a condition affecting older people, it likely starts much earlier
Next Pharmacist struck off over illicit images of kids

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.